Adient Adopts NOL Poison Pill With 4.95% Trigger, Shields $3.5B of Tax Assets
ADNT is trading near its 52-week low of $15.91 (6.3% above the low).
Summary
Adient adopted a tax benefits preservation plan with a 4.95% ownership trigger and an $83.50 rights exercise price to protect U.S. tax attributes that can offset about $3.5 billion of future taxable income. The rights are not currently exercisable, so there is no dilution today; shareholders will vote on ratification at the next annual meeting.
Key Events · Corporate Governance and Compliance · ADNT
-
NOL Poison Pill Adopted
Board adopted a Tax Benefits Preservation Plan dated November 4, 2026 with Broadridge as rights agent; one right per ordinary share for holders of record on November 16, 2026, each entitling the holder to buy one one-thousandth of a participating preferred share at $83.50.
-
4.95% Ownership Trigger
Rights become exercisable if a person or group acquires 4.95% or more of outstanding shares without board approval; existing 4.95%+ holders are grandfathered but cannot add shares without becoming an 'acquiring person.'
-
Protects $3.5B Tax Asset
Adient's U.S. net operating loss carryforwards and other tax attributes may offset approximately $3.5 billion of future taxable income, reducing future cash tax payments; a Section 382 ownership change would limit their use.
-
No Dilution Until Separation
Rights trade with the shares and are not exercisable until a separation event, so no shares are issued and no dilution occurs now; the board can redeem the rights at any time.
Analysis · ADNT · Manufacturing
Adient's board adopted a Tax Benefits Preservation Plan — a shareholder rights plan — to keep the company from tripping a Section 382 'ownership change' that would cap its use of U.S. net operating losses. Those attributes can offset roughly $3.5 billion of future taxable income, so the plan protects real future cash flow. The practical effect: anyone crossing 4.95% without board approval becomes an 'acquiring person' and their rights go void, which raises the cost of a hostile stake build and makes an unsolicited takeover harder. Existing 4.95%+ holders are grandfathered but cannot add shares. The rights (one per share, record date November 16, 2026) only separate and become exercisable on a triggering event, so there is no dilution today. The plan expires November 4, 2027 unless shareholders ratify it, in which case it runs to November 4, 2029 — the company says it will seek approval at the next annual meeting. The same release also upsized the buyback authorization by $400M to a $1 billion total with $435M remaining, a separate capital-return action disclosed in the concurrent earnings 8-K.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ADNT was trading at $16.92 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $15.91 to $27.32. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.